Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
1.750
+0.040 (2.34%)
At close: Jul 16, 2025, 4:00 PM
1.760
+0.010 (0.57%)
After-hours: Jul 16, 2025, 7:32 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023
Period Ending
Dec '23
Rare Disease Therapies
12.43M